600812 华北制药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额661,4461,229,5651,024,2671,004,3911,050,242
投资活动产生之现金流量净额(619,406)(946,732)(881,755)(528,465)(779,264)
筹资活动产生之现金流量净额(132,651)462,737(704,143)(4,478,604)314,576
汇率变动对现金及现金等价物的影响3,04011,82912,0688,438(3,135)
现金及现金等价物净增加/(减少)(87,571)757,399(549,563)(3,994,240)582,420
期初现金及现金等价物余额1,262,404505,0051,054,5685,048,8084,466,388
期末现金及现金等价物余额1,174,8331,262,404505,0051,054,5685,048,808